(Please refer to the color chart for color comparison)
The test strips aid in the detection of urine adulteration for drugs of abuse test screens. The test is based on the chemical reaction to the reagents on the pads with components in the urine sample effecting color changes. Results are obtained by comparing the color on each of the test pads with a corresponding color chart.
Oxidants/PCC (Pyridinium chlorochromate): Tests for presence of oxidizing reagents and PCC. Normal Urine contains no trace of oxidants or PCC. A dark blue or green color may indicate their presence.
Specific gravity: Tests for sample dilution. Green to dark yellow indicates normal range. Blue and bright yellow indicate abnormal ranges. Normal range is between 1.003 and 1.030.
pH: Tests for the presence of acidic or alkaline adulterants in urine. Normal pH will range from 4.0 to 9.0 and have an orange color. Colors outside the normal range will vary from pink (low pH) to dark brown (high pH).
Nitrites: Tests for the presence of nitrites which can cause discrepancies between the initial screening result and the GC/MS confirmation testing. Nitrites are not a normal component of urine. Abnormal nitrite levels (above 50mg/dl) will have red to dark red color.
Gtutaraldehyde: Tests for the presence of glutaraldehyde which can alter the test result and produce a false negative result. Normal urine should contain no Glutaraldehyde. A purple color indicates the presence of glutaraldehyde.
Creatinine: Normal urine samples contain Creatinine between 20 and 350 mg/dl (milligrams per deciliter). A specimen with a Creatinine level below 20 is considered dilute.
A procedural control is included in the test. A red line appearing in the control region (C) is considered an internal procedural control. It confirms sufficient specimen volume, adequate membrane wicking and correct procedural technique.
Control standards are not supplied with this kit. However, it is recommended that positive and negative controls be tested as good laboratory practice to confirm the test procedure and to verify proper test performance.
Accuracy
A side-by-side comparison was conducted using the Split-Specimen Cup™ and commercially available drug rapid tests. Testing was performed on approximately 300 specimens per drug type previously collected from subjects presenting for Drug Screen Testing. Presumptive positive results were confirmed by GC/MS. The following compounds were quantified by GC/MS and contributed to the total amount of drugs found in presumptive positive urine samples tested.
|
Test |
Compounds Contributed to the Totals of GC/MS |
|
AMP |
Amphetamine |
|
BAR |
Secobarbital, Butalbital, Phenobarbital, Pentobarbital |
|
BZO |
Oxazepam, Nordiazepam, a-OH-Aiprazolam, Desalkylflurazepam |
|
COC |
Benzoylecgonine |
|
THC |
11-nor-A -tetrahydrocannabinol-9-carboxylic acid |
|
MTD |
Methadone |